No evidence for activation of the unfolded protein response in neuronopathic models of Gaucher disease
- PMID: 19193629
- DOI: 10.1093/hmg/ddp061
No evidence for activation of the unfolded protein response in neuronopathic models of Gaucher disease
Abstract
Gaucher disease (GD), the most common lysosomal storage disorder (LSD), is caused by defects in the activity of the lysosomal enzyme, glucocerebrosidase, resulting in intracellular accumulation of glucosylceramide (GlcCer). Neuronopathic forms, which comprise only a small percent of GD patients, are characterized by neurological impairment and neuronal cell death. Little is known about the pathways leading from GlcCer accumulation to neuronal death or dysfunction but defective calcium homeostasis appears to be one of the pathways involved. Recently, endoplasmic reticulum stress together with activation of the unfolded protein response (UPR) has been suggested to play a key role in cell death in neuronopathic forms of GD, and moreover, the UPR was proposed to be a common mediator of apoptosis in LSDs (Wei et al. (2008) Hum. Mol. Genet. 17, 469-477). We now systematically examine whether the UPR is activated in neuronal forms of GD using a selection of neuronal disease models and a combination of western blotting and semi-quantitative and quantitative real-time polymerase chain reaction. We do not find any changes in either protein or mRNA levels of a number of typical UPR markers including BiP, CHOP, XBP1, Herp and GRP58, in either cultured Gaucher neurons or astrocytes, or in brain regions from mouse models, even at late symptomatic stages. We conclude that the proposition that the UPR is a common mediator for apoptosis in all neurodegenerative LSDs needs to be re-evaluated.
Similar articles
-
Enhanced calcium release in the acute neuronopathic form of Gaucher disease.Neurobiol Dis. 2005 Feb;18(1):83-8. doi: 10.1016/j.nbd.2004.09.004. Neurobiol Dis. 2005. PMID: 15649698
-
Spatial and temporal correlation between neuron loss and neuroinflammation in a mouse model of neuronopathic Gaucher disease.Hum Mol Genet. 2011 Apr 1;20(7):1375-86. doi: 10.1093/hmg/ddr019. Epub 2011 Jan 20. Hum Mol Genet. 2011. PMID: 21252206
-
Altered expression and distribution of cathepsins in neuronopathic forms of Gaucher disease and in other sphingolipidoses.Hum Mol Genet. 2010 Sep 15;19(18):3583-90. doi: 10.1093/hmg/ddq273. Epub 2010 Jul 8. Hum Mol Genet. 2010. PMID: 20616152
-
Neuronal forms of Gaucher disease.Handb Exp Pharmacol. 2013;(216):405-19. doi: 10.1007/978-3-7091-1511-4_20. Handb Exp Pharmacol. 2013. PMID: 23563668 Review.
-
The unfolded protein response during prostate cancer development.Cancer Metastasis Rev. 2009 Jun;28(1-2):219-23. doi: 10.1007/s10555-008-9180-5. Cancer Metastasis Rev. 2009. PMID: 19172382 Review.
Cited by
-
Unfolded protein response in Gaucher disease: from human to Drosophila.Orphanet J Rare Dis. 2013 Sep 11;8:140. doi: 10.1186/1750-1172-8-140. Orphanet J Rare Dis. 2013. PMID: 24020503 Free PMC article.
-
Recent advances in our understanding of neurodegeneration.J Neural Transm (Vienna). 2009 Sep;116(9):1111-62. doi: 10.1007/s00702-009-0240-y. Epub 2009 Jun 5. J Neural Transm (Vienna). 2009. PMID: 19707851 Review.
-
Augmentation of phenotype in a transgenic Parkinson mouse heterozygous for a Gaucher mutation.Brain. 2014 Dec;137(Pt 12):3235-47. doi: 10.1093/brain/awu291. Epub 2014 Oct 27. Brain. 2014. PMID: 25351739 Free PMC article.
-
Multi-system disorders of glycosphingolipid and ganglioside metabolism.J Lipid Res. 2010 Jul;51(7):1643-75. doi: 10.1194/jlr.R003996. Epub 2010 Mar 8. J Lipid Res. 2010. PMID: 20211931 Free PMC article. Review.
-
Modeling neuronopathic storage diseases with patient-derived culture systems.Neurobiol Dis. 2019 Jul;127:147-162. doi: 10.1016/j.nbd.2019.01.018. Epub 2019 Feb 19. Neurobiol Dis. 2019. PMID: 30790616 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous